Michel Briejer is a managing partner at Thuja Capital Management, a venture capital fund manager, which he joined early 2008. Prior to this. he held a variety of senior management positions, both in the international pharmaceutical industry (Janssen Pharmaceutica and Yamanouchi), as well as in the biotech industry (Crucell). In addition, he worked as a consultant to a number of small pharmaceutical and biotech start-up companies.
Michel holds a MSc degree in Pharmacy (Utrecht University), a PhD in Pharmacology (Wageningen University), and a post-doctoral degree in Pharmaceutical Medicine (DipPharMed, European Center for Pharmaceutical Sciences, Basle). Michel authored over 25 peer reviewed scientific papers and book chapters on pharmacology and drug development.